LENZ Therapeutics Inc Financial Flexibility Index

Latest as of June 2026: -2.23x

LENZ Therapeutics Inc financial flexibility index. LENZ Therapeutics Inc (LENZ) has a Financial Flexibility Index of -2.23x as of June 2026. Free cash flow of $-38.70 Million (operating CF $-38.71 Million minus capex $16.00K) represents -2% of total liabilities ($17.33 Million).

Financial Flexibility Index

-2.23x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-38.70 Million
Operating CF − Capex

Total Liabilities

$17.33 Million
USD

Capital Expenditures

$16.00K
USD

Financial Flexibility Index of LENZ Therapeutics Inc (2019–2025)

Financial flexibility index of LENZ Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for LENZ Therapeutics Inc across 7 annual periods. Explore how well can LENZ Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.

LENZ Therapeutics Inc Financial Flexibility Index by Year (2019–2025)

LENZ Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for LENZ Therapeutics Inc. For the full cash flow conversion analysis, see LENZ cash generation efficiency.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -3.17x $-68.34 Million $-69.17 Million $21.54 Million ▲ +39.6%
2024 -5.25x $-58.92 Million $-59.39 Million $11.22 Million ▼ -1319.2%
2023 -0.37x $-60.35 Million $-60.38 Million $163.09 Million ▲ +67.7%
2022 -1.14x $-81.39 Million $-87.98 Million $71.12 Million ▲ +20.9%
2021 -1.45x $-47.11 Million $-52.85 Million $32.55 Million ▼ -552.8%
2020 -0.22x $-7.18 Million $-8.72 Million $32.36 Million ▼ -2495.4%
2019 -0.01x $-19.00K $-19.00K $2.22 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities